The recent crisis has highlighted the polarities and the decisions sometimes surprising to doctors who also hold advisory roles or executive in the high-level (Scientific Council, the High Council of Public Health)
Professor Perronne recalled that it had put in place a system of declaration of conflict of interest prior to any decision-making process, up to leaving people out of decisions or debates if necessary.
In early 2020, the collective Data+Local across the database data Transparency Health, put in place after the scandal of the Mediator. 30 000 practitioners divided into 32 CHU of the land are shared more than 92 million, plus about 78 million euros paid under particular agreements between the university hospital and laboratories. All this does, of course, takes no account of the aid paid to the associations of victims and / or patients.
Here are the Top 13 of the rankings in annual revenues, recent paid by the pharmaceutical industry
N°1. The Palme d’or returns to the Pr François Raffi , Nantes, france. 541.729 €, of which 52.812 € Gilead. Is it a coincidence that we are taught that the phone call anonymous to threaten Didier Raoult, if he tried it with hydroxychloroquine, is the party of the portable telephone of the service of infectious diseases of the CHU of Nantes, François Raffi is head of department ? Surely a pure coincidence.
N°2. The Pr Jacques Reynes from Montpellier. 291.741 €, of which 48.006 € Gilead and 64.493 € Abbvie. Gold Jacques Reynes had been asked by Olivier Véran is to drive the clinical trial protocol Raoult in Montpellier while he is at the same time the national coordinator of two studies on the remdesivir for the account of Gilead. He had certainly not had time to send to the Minister its public Declaration of interests (DPI).
N°3. The Pr Karine Lacombe , Paris – Saint Antoine. 212.209 €, of which 28.412 € Gilead. It is on the last step of the podium, but the main thing is to be there. It’s not the podium with the Ministers at Matignon.
N°4. The Pr Jean-Michel Molina from Paris – St. Louis. 184.034 € 26.950 € Gilead and 22.864 € Abbvie. Gold Jean-Michel Molina is the co-author of an article published in Medicine and Infectious Diseases in a few cases, to say that the hydroxychloroquine does not work. Medicine and Infectious Diseases is the official journal of the SPILF (Société de Pathologie infectieuse de Langue Française).
N°5. The Pr Gilbert Deray Paris. 160.649€. A handsome sum of money to a nephrologist, who are very present on the boards tv. Attention the remdesivir can be very toxic to the kidneys.
N°6. The Pr Jean-Paul Stahl , Grenoble, france. 100.358 € 4.552 € Abbvie. It should be noted that this amount was not reported on his DPI. Gold Jean-Paul Stahl is the editor-in-chief of the journal Medicine and Infectious Diseases. It is he who has compared the Plaquenil* to toilet paper.
N°7. The Pr Christian Chidiac , Lyon, france. 90.741 €, of which 16.563 € Gilead. Gold Christian Chidiac is the president of the Commission for communicable Diseases of High Public Health Council which has made the famous Notice prohibiting hydroxychloroquine, except for the dying and asking to include the sick in the official trials (and therefore Discovery). His assistant, the Pr Florence Ader, quoted below, is the lead investigator of Discovery. Pure coincidence.
N°8. The Pr Bruno Hoen of the Pasteur Institute. 82.610 € 52.012 € Gilead. It should be noted that on its IPR, he noted they received 1000 € of Gilead ! Gold Bruno Hoen attacked the team of Marseille in an e-mail of 18 march 2020, shared with all the infectious disease physicians.
N°9. The Pr Pierre Tattevin of Rennes. 79.956 €, of which 15.028 € Gilead. It should be noted that on its DPI, like his predecessor, he noted they received 1000 € of Gilead ! It must be overwork. Gold Pierre Tattevin is president of the SPILF. This learned Society has attacked the hydroxychloroquine to encourage inclusions in Discovery, as well as in the other studies by a random draw with groups of patients not treated (randomized studies).
N°10. The Pr Vincent Le Moing of Montpellier. 68.435 € 4.776 € Gilead and 9.642 € Abbvie. Gold Vincent Le Moing driver, with his boss, Jacques Reynes cited above, the clinical trial of Montpellier.
N°11. The Dr. Alain Makinson of Montpellier. 63.873 €, 15.054 € Gilead. Gold Alain Makinson participates in the study of Montpellier with Jacques Reynes and Vincent Le Moing. A beautiful trio. Montpellier is very well represented.
N°12. François-Xavier Lescure , Paris – Bichat. 28.929 € 8.621 € Gilead. Gold Francois-Xavier Lescure is the assistant to our famous Yazdan Yazdanpanah, which is in the scientific Board Covid-19. He publicly criticized the team of Marseilles to discredit the hydroxychloroquine. He is the co-author of the study highly questionable on the remdésivir of Gilead, published in the New England Journal of Medicine. However, this study has no methodology.
N°13. The Pr Florence Ader , Lyon, france. 11.842 € , 3.750 € of Gilead. Gold Florence Ader is the lead investigator of Discovery.
From the twelve, it starts to make an outbreak !